Product Development Policy | Research & Development | SENJU Pharmaceutica
the economic burden on patients by using various generic drugs and biosimilars. In addition, there are various other eye diseases. The World Report on Vision issued by the WHO in 2019 reports that mo...
http://www.senju.co.jp/english/rd/policy/